Next Article in Journal
Anticancer Therapy with HDAC Inhibitors: Mechanism-Based Combination Strategies and Future Perspectives
Next Article in Special Issue
The PARP Enzyme Family and the Hallmarks of Cancer Part 1. Cell Intrinsic Hallmarks
Previous Article in Journal
The Prognostic Value of the De Ritis Ratio for Progression-Free Survival in Patients with NET Undergoing [177Lu]Lu-DOTATOC-PRRT: A Retrospective Analysis
 
 
Article

Article Versions Notes

Cancers 2021, 13(4), 633; https://doi.org/10.3390/cancers13040633
Action Date Notes Link
article xml file uploaded 5 February 2021 12:10 CET Original file -
article xml uploaded. 5 February 2021 12:10 CET Update -
article pdf uploaded. 5 February 2021 12:10 CET Version of Record https://www.mdpi.com/2072-6694/13/4/633/pdf-vor
article supplementary file uploaded. 5 February 2021 12:10 CET - https://www.mdpi.com/2072-6694/13/4/633#supplementary
article html file updated 5 February 2021 12:11 CET Original file -
article xml file uploaded 23 February 2021 07:11 CET Update -
article xml uploaded. 23 February 2021 07:11 CET Update https://www.mdpi.com/2072-6694/13/4/633/xml
article pdf uploaded. 23 February 2021 07:11 CET Updated version of record https://www.mdpi.com/2072-6694/13/4/633/pdf
article html file updated 23 February 2021 07:12 CET Update -
article html file updated 24 July 2022 16:20 CEST Update https://www.mdpi.com/2072-6694/13/4/633/html
Back to TopTop